All data are based on the daily closing price as of March 13, 2026
o

Olympus

7733.TSE
8.23 USD
-0.21
-2.49%

Overview

Last close
8.23 usd
Market cap
9.06B usd
52 week high
18.83 usd
52 week low
8.23 usd
Target price
11.82 usd

Valuation

P/E
15.1748
Forward P/E
21.0084
Price/Sales
1.4612
Price/Book Value
1.9086
Enterprise Value
9.50B usd
EV/Revenue
1.5517
EV/EBITDA
7.1885

Key financials

Revenue TTM
6.18B usd
Gross Profit TTM
4.10B usd
EBITDA TTM
1.30B usd
Earnings per Share
0.54 usd
Dividend
0.13 usd
Total assets
9.31B usd
Net debt
436.48M usd

About

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat; and gastroenterology devices and gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
  • Symbol
    7733.TSE
  • Exchange
    TSE
  • Isin
    JP3201200007
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Stephen Kneebone
  • Headquarter
    Hachioji
  • Web site
    https://www.olympus.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top